It will receive follow-on capital from existing backer Alphabet. The London-based company’s goal is an ambitious one – to “solve all disease,” according to the Isomorphic Labs site.

Thrive Capital led the financing round with participation from Google’s GV, and follow-on capital from Alphabet, its parent company and an existing investor. Isomorphic Labs described plans to ...

Isomorphic Labs has raised a whopping $600 million to ... The start-up – which has emerged from Google parent Alphabet's DeepMind project and is led by DeepMind founder Sir Demis Hassabis ...

Isomorphic Labs raised $600 million in its first external funding round, led by Thrive Capital with participation from GV and Alphabet, according to the Financial Times. The AI-first drug design ...

Google parent Alphabet has drawn on its DeepMind artificial intelligence division to form a drug discovery unit that it calls Isomorphic Labs. The UK-registered company will be able to tap into ...

The fledgling company was Isomorphic Labs, the secretive artificial intelligence ... While Isomorphic is an independent unit of Google parent Alphabet, Hassabis' dual roles reflect the intertwined ...